These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34310015)

  • 21. Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes.
    Marks JD; Syrjanen JA; Graff-Radford J; Petersen RC; Machulda MM; Campbell MR; Algeciras-Schimnich A; Lowe V; Knopman DS; Jack CR; Vemuri P; Mielke MM;
    Alzheimers Res Ther; 2021 Dec; 13(1):199. PubMed ID: 34906229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
    JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study.
    Götze K; Vrillon A; Bouaziz-Amar E; Mouton-Liger F; Hugon J; Martinet M; Dumurgier J; Cognat E; Zetterberg H; Blennow K; Hourrègue C; Paquet C; Lilamand M
    Neurobiol Dis; 2023 Jan; 176():105937. PubMed ID: 36462720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular Depression and Cognition in Mexican Americans.
    Johnson LA; Large SE; Izurieta Munoz H; Hall JR; O'Bryant SE
    Dement Geriatr Cogn Disord; 2019; 47(1-2):68-78. PubMed ID: 30861514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Andreasson U; Zetterberg H; Blennow K;
    JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.
    Zetterberg H; Skillbäck T; Mattsson N; Trojanowski JQ; Portelius E; Shaw LM; Weiner MW; Blennow K;
    JAMA Neurol; 2016 Jan; 73(1):60-7. PubMed ID: 26524180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
    JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma Biomarkers of Alzheimer's Disease Are Associated with Physical Functioning Outcomes Among Cognitively Normal Adults in the Multiethnic HABS-HD Cohort.
    O'Bryant SE; Petersen M; Hall JR; Large S; Johnson LA;
    J Gerontol A Biol Sci Med Sci; 2023 Jan; 78(1):9-15. PubMed ID: 35980599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Health & Aging Brain among Latino Elders (HABLE) study methods and participant characteristics.
    O'Bryant SE; Johnson LA; Barber RC; Braskie MN; Christian B; Hall JR; Hazra N; King K; Kothapalli D; Large S; Mason D; Matsiyevskiy E; McColl R; Nandy R; Palmer R; Petersen M; Philips N; Rissman RA; Shi Y; Toga AW; Vintimilla R; Vig R; Zhang F; Yaffe K;
    Alzheimers Dement (Amst); 2021; 13(1):e12202. PubMed ID: 34189247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals.
    Sun Q; Ni J; Wei M; Long S; Li T; Fan D; Lu T; Shi J; Tian J
    Front Aging Neurosci; 2022; 14():963845. PubMed ID: 36062146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's disease.
    Sugarman MA; Zetterberg H; Blennow K; Tripodis Y; McKee AC; Stein TD; Martin B; Palmisano JN; Steinberg EG; Simkin I; Budson AE; Killiany R; O'Connor MK; Au R; Qiu WWQ; Goldstein LE; Kowall NW; Mez J; Stern RA; Alosco ML
    Neurobiol Aging; 2020 Oct; 94():60-70. PubMed ID: 32585491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma neurofilament light chain levels in Alzheimer's disease.
    Zhou W; Zhang J; Ye F; Xu G; Su H; Su Y; Zhang X;
    Neurosci Lett; 2017 May; 650():60-64. PubMed ID: 28428015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurofilament Light Chain as a Potential Biomarker in Plasma for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and a Meta-Analysis.
    Fan Z; Liu X; Liu J; Chen C; Zhou M
    J Integr Neurosci; 2023 Jun; 22(4):85. PubMed ID: 37519166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.
    Quiroz YT; Zetterberg H; Reiman EM; Chen Y; Su Y; Fox-Fuller JT; Garcia G; Villegas A; Sepulveda-Falla D; Villada M; Arboleda-Velasquez JF; Guzmán-Vélez E; Vila-Castelar C; Gordon BA; Schultz SA; Protas HD; Ghisays V; Giraldo M; Tirado V; Baena A; Munoz C; Rios-Romenets S; Tariot PN; Blennow K; Lopera F
    Lancet Neurol; 2020 Jun; 19(6):513-521. PubMed ID: 32470423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comorbid Depression and Diabetes as a Risk for Mild Cognitive Impairment and Alzheimer's Disease in Elderly Mexican Americans.
    Johnson LA; Gamboa A; Vintimilla R; Cheatwood AJ; Grant A; Trivedi A; Edwards M; Hall JR; O'Bryant SE
    J Alzheimers Dis; 2015; 47(1):129-36. PubMed ID: 26402761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Value of Plasma Amyloid-β, Total Tau, and Neurofilament Light for Identification of Early Alzheimer's Disease.
    Shi Y; Lu X; Zhang L; Shu H; Gu L; Wang Z; Gao L; Zhu J; Zhang H; Zhou D; Zhang Z
    ACS Chem Neurosci; 2019 Aug; 10(8):3479-3485. PubMed ID: 31145586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma neurofilament light levels correlate with white matter damage prior to Alzheimer's disease: results from ADNI.
    Nabizadeh F; Balabandian M; Rostami MR; Kankam SB; Ranjbaran F; Pourhamzeh M;
    Aging Clin Exp Res; 2022 Oct; 34(10):2363-2372. PubMed ID: 35226303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship of CRP and cognition in cognitively normal older Mexican Americans: A cross-sectional study of the HABLE cohort.
    Vintimilla R; Hall J; Johnson L; O'Bryant S
    Medicine (Baltimore); 2019 May; 98(19):e15605. PubMed ID: 31083252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The age-dependent associations of white matter hyperintensities and neurofilament light in early- and late-stage Alzheimer's disease.
    Walsh P; Sudre CH; Fiford CM; Ryan NS; Lashley T; Frost C; Barnes J;
    Neurobiol Aging; 2021 Jan; 97():10-17. PubMed ID: 33070094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study.
    Carmona-Iragui M; Alcolea D; Barroeta I; Videla L; Muñoz L; Van Pelt KL; Schmitt FA; Lightner DD; Koehl LM; Jicha G; Sacco S; Mircher C; Pape SE; Hithersay R; Clare ICH; Holland AJ; Nübling G; Levin J; Zaman SH; Strydom A; Rebillat AS; Head E; Blesa R; Lleó A; Fortea J
    Lancet Neurol; 2021 Aug; 20(8):605-614. PubMed ID: 34302785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.